Elevated expression of angiogenin in prostate cancer and its precursors

Clinical Cancer Research

Volumn 11, Issue 23, 2005, Pages 8358-8363

  Katona, Terrence M ^a   Neubauer, Blake Lee ^b   Iversen, Philip W ^b   Zhang, Shaobo ^a   Baldridge, Lee Ann ^a   Cheng, Liang ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN EXPRESSION; SCORING SYSTEM;

ADENOCARCINOMA; ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RIBONUCLEASE, PANCREATIC; TREATMENT OUTCOME;

EID: 28544451102     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0962     Document Type: Article

References (48)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
2. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N EnglJ Med 1995;333:1751-63.
3. Izawa JI, Dinney CP. The role of angiogenesis in prostate and other urologic cancers: a review. Can Med Assoc J 2001;164:662-70.
4. Olson KA, Byers HR, Key ME, Fett JW. Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. Int J Cancer 2002;98:923-9.
5. Olson KA, Fett JW, French TC, Key ME, Vallee BL. Angiogenin antagonists prevent tumor growth in vivo. Proc Natl Acad Sci U S A 1995;92:442-6.
6. Hu G, Riordan JF, Vallee BL. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc Natl Acad Sci U S A 1994;91:12096-100.
7. Hisai H, Kato J, Kobune M, et al. Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity. Clin Cancer Res 2003;9: 4852-9.
8. Acharya KR, Shapire R, Riordan JF, Vallee BL. Crystal structure of bovine angiogenin at 1.5-A resolution. Proc Natl Acad Sci U S A 1995;92:2949-53.
9. Russo N, Acharya KR, Vallee BL, Shapiro R. A combined kinetic and modeling study of the catalytic center subsites of human angiogenin. Proc Natl Acad Sci U S A 1996;93:804-8.
10. Malamitsi-Puchner A, Sarandakou A, Dafogianni C, Tziotis J, Bartsocas CS. Serum angiogenin levels in children and adolescents with insulin-dependent diabetes mellitus. Pediatr Res 1998;43:798-800.
11. Weiner HL, Weiner LH, Swain JL. Tissue distribution and developmental expression of the messenger RNA encoding angiogenin. Science 1987;237:280-2.
12. Burgmann H, Hollenstein U, Maca T, et al. Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease. J Clin Pathol 1996;49:508-10.
13. Shaarawy M, El-Mallah SY, Sheiba M. Angiogenin and gestational trophoblastic tumors, a promising prognostic marker. Clin Chem Lab Med 2003;41: 306-10.
14. Shimoyama S, Gansauge F, Gansauge S, Negri G, Oohara T, Beger HG. Increased angiogenin expression in pancreatic cancer is related to aggressiveness. Cancer Res 1996;56:2703-6.
15. Shimoyama S, Yamasaki K, Kawahara M, Kaminishi M. Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression. Clin Cancer Res 1999;5:1125-30.
16. Shimoyama S, Kaminishi M. Increased angiogenin expression in gastric cancer correlated with cancer progression. J Cancer Res Clin Oncol 2000;126: 468-74.
17. Shimoyama S, Kaminishi M. Angiogenin in sera as an independent prognostic factor in gastric cancer. J Cancer Res Clin Oncol 2003;129:239-44.
18. Barton DPJ, Cai A, Wendt K, Young M, Bamero A, De Cesare S. Angiogenic protein expression in advanced epithelial ovarian cancer. Clin Cancer Res 1997;3:1579-86.
19. Miyake J, Jara L, Yamanaka K, Gohji K, Arakawa S, Kamidono S. Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence. Cancer 1999;86:316-24.
20. Hartmann A, Kunz M, Kostlin S, et al. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res 1999;59:1578-83.
21. Ugurel S, Rappl G, Tilgen W, Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol 2001;19:577-83.
22. Homer JJ, Greenman J, Stafford ND. Angiogenesis in head and neck squamous cell carcinoma. Clin Otolaryngol 2000;25:169-80.
23. Borre M, Offersen BV, Nerstrom B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 1998;78:940-4.
24. Choy M, Rafii S. Role of angiogenesis in the progression and treatment of prostate cancer. Cancer Invest 2001;19:181-91.
25. Olson KA, Byers HR, Key ME, Fett JW. Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin Cancer Res 2001;7:3598-605.
26. Reisdorf C, Abergel D, Bontems F, Lallemand JY. Proton resonance assignments and secondary structure of bovine angiogenin. Eur J Biochem 1994;224: 811-22.
27. Kishimoto K, Liu S, Tsuji T, Olson KA, Hu G. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 2005;24:445-56.
28. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical stage. J Urol 1974;111:58-64.
29. Fleming ID, Cooper JS, Henson DE, et al. AJCC cancer staging manual. Philadelphia: Raven and Lippincott; 1997.
30. Jiang J, Neubauer BL, Graft JR, et al. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Pathol 2002;160:667-71.
31. Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001; 91:66-73.
32. Majumder PK, Yeh JJ, George DJ, et al. Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model. Proc Natl Acad Sci U S A 2003;100:7841-6.
33. Cheng L, Nagabhushan M, Pretlow TP, Amini SB, Pretlow TG. Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol 1996;148: 1375-80.
34. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 1995;57:289-300.
35. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate. Am J Pathol 1999;155:1985-92.
36. De Marzo AM, Meeker AK, Zha S, et al. Human prostate cancer precursors and pathobiology. Urology 2003;62:(5 suppl 1):55-62.
37. Fett JW, Strydom DJ, Lobb RR, et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985;24: 5480-6.
38. King TV, Vallee BL. Neovascularisation of the meniscus with angiogenin. An experimental study in rabbits. J Bone Joint Surg Br 1991;73:587-90.
39. Newton DL, Xue Y, Olson KA, Fett JW, Rybak SM. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains. Biochemistry 1996;35:545-53.
40. Shapiro R, Riordan JF, Vallee BL. Characteristic ribonucleolytic activity of human angiogenin. Biochemistry 1986;25:3527-32.
41. Youle RJ, Newton D, Wu YN, Gadina M, Rybak SM. Cytotoxic ribonucleases and chimeras in cancer therapy. Crit Rev Ther Drug Carrier Syst 1993;10:1-28.
42. Hu GF, Strydom DJ, Fett JW, Riordan JF, Vallee BL. Actin is a binding protein for angiogenin. Proc Natl Acad Sci U S A 1993;90:1217-21.
43. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-7.
44. Folkman J, Watson K. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;31:58-61.
45. Shekhar MPV, Werdell J, Tait L. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen. Cancer Res 2001;60:439-49.
46. Campbell S. Advances in angiogenesis research: relevance to urological oncology. J Urol 1997;158: 1663-74.
47. Etoh T, Shibuta K, Barnard GF, Kitano S, Mori M. Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin Cancer Res 2000;6:3545-51.
48. Shimoyama S, Shimizu N, Tsuji E, Yamasaki K, Kawahara M, Kaminishi M. Distribution of angiogenin and its gene message in colorectal cancer patients and their clinical relevance. Anticancer Res 2002;22:1045-52.